Area of research
Epidemiology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Congenital Heart Disease Studies, Cardiovascular Function and Risk Factors, Diet and metabolism studies, and Metabolomics and Mass Spectrometry Studies.
The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD <sup>+</sup> Therapy in HFpEF
Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF
Echocardiographic Predictors of Cardiovascular Outcome in Heart Failure with Preserved Ejection Fraction
Leveraging metabolism for better outcomes in heart failure
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Impact of dietary carbohydrate type and protein–carbohydrate interaction on metabolic health
A hierarchical approach to removal of unwanted variation for large-scale metabolomics data
Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms—A Narrative Review
Plasma levels of trimethylamine-N-oxide can be increased with ‘healthy’ and ‘unhealthy’ diets and do not correlate with the extent of atherosclerosis but with plaque instability
Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy
Disulfiram Treatment Normalizes Body Weight in Obese Mice
Effect of chronic exercise in healthy young male adults: a metabolomic analysis
Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome
Branched-chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control
Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot
Are Lifestyle Therapies Effective for NAFLD Treatment?
Impact of the Food Additive Titanium Dioxide (E171) on Gut Microbiota-Host Interaction
Beta-Aminoisobutyric Acid as a Novel Regulator of Carbohydrate and Lipid Metabolism
Ingestion of resistant starch by mice markedly increases microbiome‐derived metabolites
Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study
TRAIL-Expressing Monocyte/Macrophages Are Critical for Reducing Inflammation and Atherosclerosis
Utilizing <i>state‐of‐the‐art</i> “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease
Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease
Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes
Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis
Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease
Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis
miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI
Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells